Lifecore Biomedical, Inc. Overview
Pro stress-test →Lifecore Biomedical is a fully integrated Contract Development and Manufacturing Organization (CDMO) offering expertise in specialty formulation, aseptic filling, and final packaging of both complex medical devices and injectable pharmaceuticals. The company has been a leading manufacturer of pharmaceutical-grade hyaluronic acid since 1981 and its products have been used in the treatment of more than 100 million patients worldwide.
Strategic Profile
Pro stress-test →Lifecore offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products and brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical companies across multiple therapeutic categories. The company was recently added to the Nasdaq Biotech Index, reflecting its growing market presence.
Competitive Landscape
Pro stress-test →Lifecore competes in the CDMO sector against larger players like Catalent, Emergent BioSolutions, and Patheon, as well as specialized injectables manufacturers. Its competitive advantages lie in proprietary hyaluronic acid expertise, specialized capabilities in sterile injectable manufacturing, and long-standing customer relationships. The CDMO market is consolidating, with larger contract manufacturers integrating services.
Industry Context
Lifecore Biomedical, Inc. operates in Pharmaceutical Contract Development and Manufacturing Organization (CDMO) / Specialty Chemicals.
Key facts
Founded: 1981 · Headquarters: Chaska, Minnesota, US · Market cap: $324M